Literature DB >> 16313975

Performance evaluation of three automated human immunodeficiency virus antigen-antibody combination immunoassays.

Jung-Ah Kwon1, Soo-Young Yoon, Chang-Kyu Lee, Chae Seung Lim, Kap No Lee, Hyun Ju Sung, Catherine A Brennan, Sushil G Devare.   

Abstract

Three fourth-generation antigen/antibody combination assays (Elecsys, AxSYM, Architect HIV) and two third-generation (AxSYM, Centaur) HIV antibody immunoassays were evaluated. The evaluation panel of 479 samples included: nine tissue culture derived HIV-1 strains at four different p24 antigen concentrations (n=36), a p24 antigen sensitivity panel (n=10), 149 HIV-1 or HIV-2 confirmed antibody positive samples, ten anti-HIV-1 positive low titer samples, three seroconversion panels (n=21), and 253 HIV negative samples. The Architect had the best sensitivity for detection of HIV-1 antigen across eight HIV-1 subtypes, followed by the AxSYM while the Elecsys could not detect the highest antigen concentration evaluated (25 pg/mL) for eight of nine virus isolates. All assays showed 100% sensitivity for detection of HIV-1, group M, group O, and HIV-2 antibody positive samples. The Architect Ag/Ab Combo assay detected the first positive bleed of the three seroconversion panels and detected infection 4-26 days earlier than the third generation assays. Based on evaluation of 253 negative samples, assay specificity varied from 98.0% to 99.6%. The Architect HIV Ag/Ab Combo exhibited the best performance for specificity and detection of p24 antigen leading to closure of seroconversion window and demonstrating its utility for early diagnosis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16313975     DOI: 10.1016/j.jviromet.2005.10.013

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  18 in total

1.  Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.

Authors:  Shixing Tang; Jiangqin Zhao; Aifeng Wang; Ragupathy Viswanath; Harri Harma; Richard F Little; Robert Yarchoan; Susan L Stramer; Phillipe N Nyambi; Sherwin Lee; Owen Wood; Eric Y Wong; Xue Wang; Indira K Hewlett
Journal:  Clin Vaccine Immunol       Date:  2010-06-09

Review 2.  Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications.

Authors:  L Buonaguro; M L Tornesello; F M Buonaguro
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

3.  PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.

Authors:  Debbie L Seem; Ingi Lee; Craig A Umscheid; Matthew J Kuehnert
Journal:  Public Health Rep       Date:  2013-07       Impact factor: 2.792

4.  Short communication: Emergence of novel A/G recombinant HIV-1 strains in Argentina.

Authors:  María F Fernández; Marcelo D Golemba; Carmen Terrones; Patricia Paradiso; Juan C Nassif; Rosa Bologna; Andrea Mangano; Luisa Sen; Paula C Aulicino
Journal:  AIDS Res Hum Retroviruses       Date:  2014-12-22       Impact factor: 2.205

5.  Cost savings associated with testing of antibodies, antigens, and nucleic acids for diagnosis of acute HIV infection.

Authors:  Maile Y Karris; Christy M Anderson; Sheldon R Morris; Davey M Smith; Susan J Little
Journal:  J Clin Microbiol       Date:  2012-03-21       Impact factor: 5.948

6.  New automated chemiluminescence immunoassay for simultaneous but separate detection of human immunodeficiency virus antigens and antibodies.

Authors:  Roberto Alonso; Paula López Roa; Marisol Suárez; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2014-02-26       Impact factor: 5.948

7.  Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants.

Authors:  Véronique Lemee; Marie Leoz; Manuel Etienne; Fabienne De Oliveira; Jean-Christophe Plantier
Journal:  J Clin Microbiol       Date:  2014-06-25       Impact factor: 5.948

8.  Prolonged second diagnostic window for human immunodeficiency virus type 1 in a fourth-generation immunoassay: are alternative testing strategies required?

Authors:  C R Robert George; Peter W Robertson; M Josephine Lusk; Ross Whybin; William Rawlinson
Journal:  J Clin Microbiol       Date:  2014-09-10       Impact factor: 5.948

9.  Detection of individuals with acute HIV-1 infection using the ARCHITECT HIV Ag/Ab Combo assay.

Authors:  Susan H Eshleman; Leila Khaki; Oliver Laeyendecker; Estelle Piwowar-Manning; LeTanya Johnson-Lewis; Marla Husnik; Beryl Koblin; Thomas Coates; Margaret Chesney; Ana Vallari; Sushil G Devare; John Hackett
Journal:  J Acquir Immune Defic Syndr       Date:  2009-09-01       Impact factor: 3.731

Review 10.  p24 revisited: a landscape review of antigen detection for early HIV diagnosis.

Authors:  Eleanor R Gray; Robert Bain; Olivia Varsaneux; Rosanna W Peeling; Molly M Stevens; Rachel A McKendry
Journal:  AIDS       Date:  2018-09-24       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.